Chief medical officer Professor Dame Sally Davies announced funding for two projects
Chief medical officer Professor Dame Sally Davies announced funding for two projects
The companies aim to establish five new drug discovery programmes
Roche’s drug has been used for years to treat wet AMD, an indication for which it is not specifically licensed
Under the plans, people already living in the EU who have their healthcare funded by the UK will have their healthcare costs covered for six months
This year’s awards ceremony will be taking place at the Chelsea Harbour Hotel on the 14th November.
European regulators have cleared Bayer’s Vitrakvi (larotrectinib) as a treatment for solid tumours displaying an NTRK gene fusion.
Healthcare professionals should develop a management plan with the patient
The figures should serve as a “wake-up call’, says the BMJ.
The therapy targets cerebral adrenoleukodystrophy (CALD), the most severe manifestation of adrenoleukodystrophy (ALD), a rare metabolic disorder.
The committee has recommended seven medicines for approval at its September 2019 meeting.
Tresiba significantly reduced the rate of severe hypoglycaemia by 80% and nocturnal symptomatic hypoglycaemia by 37%.
The findings support the prescription of SSRI antidepressants in a wider group of participants than previously thought.
only 7% of children with targetable mutations were able to access the appropriate adult drug in a study.
The coveted Pharma Digital Partner award was won by Emma Prosser from MSD.
Adult smoking rates fell 2.2% from January to July 2019, the equivalent of 200 fewer smokers an hour.